Stocks advanced Friday after Bush announced details of a rescue plan for auto makers.
Drugmaker Bristol-Myers Squibb said Tuesday it will eliminate another 10 percent of its work force through 2010 as it works to pare costs before it loses patent protection on key drugs.
Drugmaker Bristol-Myers Squibb became the latest big company to announce layoffs, saying it will eliminate another 10 percent of its work force through 2010.
For months now several analysts have been pointing out that despite big pharma's many problems some of the companies still pay healthy dividends. And when T-bills are offering next to nothing, a solid dividend yield in these rough and tumble times is a good thing.
The Consumer Price Index had its biggest one month drop ever. Here is a breakdown of the inflation benchmark to show you where costs are falling most.
Pharma companies are usually considered safety plays. But might they also be growth stocks in disguise?
This week brought a slew of layoffs, including Dow component Bank of America, which said its planned job cuts may grow to 35,000 over three years after it completes its purchase of Merrill Lynch.
For the second time in two months Eli Lilly CEO John Lechleiter has called his stock price “ludicrous." But is he right?
Stocks turned mixed Thursday as a rise in commodities stocks offset pressure from a weak jobs report and a sharp drop in import prices.
Jamie Cox of Harris Financial Group is looking past the current "flight to quality" that has dropped Treasury yields so far, and saying where he thinks the money will be heading when it comes flying back.
Analysts have a one-day respite between two major pharma R & D days and they're using it to size up Merck's update yesterday and to set expectations for Eli Lilly's briefing tomorrow.
An auto industry bailout package seems inevitable Tuesday — and the dollar and U.S. stocks are riding the expectation higher. The news continued to be glum for small business owners struggling with the recession and retailers, whose holiday sales may be even weaker than expected. But top analysts told CNBC they expect a Christmas-New Year's Eve rally and see an energy stock recovery in the works.
I wrote this morning's post from the Merck analyst meeting before sitting down for my exclusive interview with Exec Veep Ken Frazier. So, I had to pass along this fresh anecdote that illustrates even more how far this drug company and its people have come.
Sony became one of the latest companies to announce layoffs in attempt to rein in costs and weather the weak economy.
Sitting here at Merck's annual drug research and development for the Street in the media room at the company's headquarters in central New Jersey. This year, for the first time, MRK is allowing reporters into the actual meeting room with the 300 or so analysts and investors
Further layoffs on Monday from big market names, including a component of the Dow Jones Industrial Average an American business icon, added to employment gloom.
The Dow fell on Thursday as a sharp drop in oil prices sent the energy sector tumbling and disappointing profit outlooks raised the specter of a worsening economy.
The bailout-nation saga continued Thursday, as the Little Three carmakers from Detroit testified all day in front of the Senate Banking Committee. So far, the best thing I heard was from Sen. Robert Corker of Tennessee...
Stocks ended sharply lower Thursday amid anxiety over a fresh round of layoffs, dismal same-store sales numbers and the prospect of tomorrow's jobs report.
Stocks opened lower Thursday amid a fresh round of layoffs and dismal same-store sales numbers, but soon turned mixed after an unexpected drop in jobless claims and better-than-expected factory-orders report.